Correlation Between Assertio Therapeutics and Cardiol Therapeutics
Can any of the company-specific risk be diversified away by investing in both Assertio Therapeutics and Cardiol Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Assertio Therapeutics and Cardiol Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Assertio Therapeutics and Cardiol Therapeutics Class, you can compare the effects of market volatilities on Assertio Therapeutics and Cardiol Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Assertio Therapeutics with a short position of Cardiol Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Assertio Therapeutics and Cardiol Therapeutics.
Diversification Opportunities for Assertio Therapeutics and Cardiol Therapeutics
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Assertio and Cardiol is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Assertio Therapeutics and Cardiol Therapeutics Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiol Therapeutics and Assertio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Assertio Therapeutics are associated (or correlated) with Cardiol Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiol Therapeutics has no effect on the direction of Assertio Therapeutics i.e., Assertio Therapeutics and Cardiol Therapeutics go up and down completely randomly.
Pair Corralation between Assertio Therapeutics and Cardiol Therapeutics
Given the investment horizon of 90 days Assertio Therapeutics is expected to generate 0.63 times more return on investment than Cardiol Therapeutics. However, Assertio Therapeutics is 1.58 times less risky than Cardiol Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Cardiol Therapeutics Class is currently generating about -0.02 per unit of risk. If you would invest 75.00 in Assertio Therapeutics on July 24, 2025 and sell it today you would earn a total of 8.00 from holding Assertio Therapeutics or generate 10.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Assertio Therapeutics vs. Cardiol Therapeutics Class
Performance |
| Timeline |
| Assertio Therapeutics |
| Cardiol Therapeutics |
Assertio Therapeutics and Cardiol Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Assertio Therapeutics and Cardiol Therapeutics
The main advantage of trading using opposite Assertio Therapeutics and Cardiol Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Assertio Therapeutics position performs unexpectedly, Cardiol Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will offset losses from the drop in Cardiol Therapeutics' long position.| Assertio Therapeutics vs. Cardiol Therapeutics Class | Assertio Therapeutics vs. INC Research Holdings | Assertio Therapeutics vs. ImageneBio, | Assertio Therapeutics vs. Unicycive Therapeutics |
| Cardiol Therapeutics vs. INC Research Holdings | Cardiol Therapeutics vs. Assertio Therapeutics | Cardiol Therapeutics vs. Nutriband | Cardiol Therapeutics vs. ImmunoPrecise Antibodies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |